Viewing Study NCT05429918


Ignite Creation Date: 2025-12-25 @ 4:34 AM
Ignite Modification Date: 2026-06-06 @ 11:01 PM
Study NCT ID: NCT05429918
Status: UNKNOWN
Last Update Posted: 2022-06-23
First Post: 2021-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years
Sponsor: Peking University Third Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mantle Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MCL View
None ibrutinib View
None aged ≤65 years View